The initiation of coverage by Keybanc with an Overweight rating and a high price target suggests a strong positive outlook for Inspire Medical Systems. This is likely to generate investor interest and could lead to a short-term increase in the stock price, given the credibility of Keybanc's analysis and the significant price target set.